Atlantic Health System/Morristown Medical Center
Hematology and Oncology fellowship · Morristown, NJ · Atlantic Health System programs · Program website
Internal Medicine residency here · Other fellowships: Rheumatology · Cardiovascular Disease
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Atlantic Health System's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
Hematology and Oncology at Atlantic Health Systemshared by every program there, not this program's own
Institution-level: all hematology and oncology publications from Atlantic Health System + Morristown Medical Center and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Hematology and Oncology research topics at Atlantic Health System
Papers in the window; each links to the list on OpenAlex.
- CAR-T cell therapy research 16
- Pancreatic and Hepatic Oncology Research 8
- Chronic Lymphocytic Leukemia Research 8
- Glioma Diagnosis and Treatment 7
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Surgical Treatments 6
- Colorectal Cancer Screening and Detection 6
- Multiple Myeloma Research and Treatments 5
Most cited at Atlantic Health System since 2024
All hematology and oncology papers there on OpenAlex
- Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 StudyTheresa Michelle Medina et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 70
- Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignanciesJay Jacoby et al. · Journal for ImmunoTherapy of Cancer · 2025 · PubMed · cited 33
- Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated resultsMazyar S. Shadman et al. · Blood Advances · 2025 · PubMed · cited 16
- Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreductionVincent M. Chung et al. · The Oncologist · 2024 · PubMed · cited 15
- OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCLYuliya P. L. Linhares et al. · Blood Advances · 2024 · PubMed · cited 23
- Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 StudyPhilip A. Philip et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 54
- Anti-B-Cell-Activating Factor (BAFF) Therapy: A Novel Addition to Autoimmune Disease Management and Potential for Immunomodulatory Therapy in Warm Autoimmune Hemolytic AnemiaMahija Cheekati et al. · Biomedicines · 2024 · PubMed · cited 18
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateJulienne E. Bower et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 328
- Normal Risk Ovarian Screening Study: 21-Year UpdateChae Young Han et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 23
- Male Breast Cancer: a Review on Diagnosis, Treatment, and SurvivorshipPrarthna V Bhardwaj et al. · Current Oncology Reports · 2024 · PubMed · cited 61
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/atlantic-health-system-morristown-medical-center-heme-onc"><img src="https://openprograms.org/programs/atlantic-health-system-morristown-medical-center-heme-onc/badge.svg" alt="Atlantic Health System/Morristown Medical Center Hematology and Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.